Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure
- 30 June 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 25 (6) , 879-886
- https://doi.org/10.1016/0272-6386(95)90570-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patientsBone, 1993
- 1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trialKidney International, 1989
- Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate bindersKidney International, 1988
- Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing DialysisNew England Journal of Medicine, 1986
- Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.Journal of Clinical Investigation, 1984
- DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROLThe Lancet, 1978
- Preservation of Function in Experimental Renal Disease by Dietary Restriction of PhosphateNew England Journal of Medicine, 1978
- Comparative study of alkaline phosphatase isoenzymes, bone histology, and skeletal radiography in dialysis bone disease.BMJ, 1977
- Skeletal resistance to the calcemic action of parathyroid hormone in uremia: Role of 1,25(OH)2D3Kidney International, 1976
- CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1976